Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 169 articles:
HTML format



Single Articles


    October 2021
  1. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
    Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
    Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  2. OLOMI W, Biraro IA, Kilonzo K, Te Brake L, et al
    Tuberculosis preventive therapy for people with diabetes mellitus.
    Clin Infect Dis. 2021 Sep 10. pii: 6368159. doi: 10.1093.
    PubMed    


  3. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38+CD27-TNF-alpha + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
    Clin Infect Dis. 2021;73:793-801.
    PubMed     Abstract available


    August 2021
  4. MARTINEZ L, Ncayiyana JR, Goddard L, Botha M, et al
    Vitamin D concentrations in infancy and the risk of tuberculosis in childhood: A prospective birth cohort in Cape Town, South Africa.
    Clin Infect Dis. 2021 Aug 26. pii: 6358095. doi: 10.1093.
    PubMed     Abstract available


  5. NWONGBOUWOH MUEFONG C, Owolabi O, Donkor S, Charalambous S, et al
    Neutrophils contribute to severity of tuberculosis pathology and recovery from lung damage pre- and post-treatment.
    Clin Infect Dis. 2021 Aug 24. pii: 6356988. doi: 10.1093.
    PubMed     Abstract available


  6. CHABALA C, Turkova A, Hesseling AC, Zimba KM, et al
    Pharmacokinetics of first-line drugs in children with tuberculosis using WHO-recommended weight band doses and formulations.
    Clin Infect Dis. 2021 Aug 22. pii: 6356214. doi: 10.1093.
    PubMed     Abstract available


  7. FRITSCHI N, Wind A, Hammer J, Ritz N, et al
    Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study.
    Clin Infect Dis. 2021 Aug 19. pii: 6354867. doi: 10.1093.
    PubMed     Abstract available


  8. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
    A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
    Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
    PubMed     Abstract available


  9. BURKE RM, Gupta Wright A
    Diagnosing Tuberculosis in People With Advanced Human Immunodeficiency Virus: More Is Needed.
    Clin Infect Dis. 2021;73:e878-e879.
    PubMed    


  10. MATOGA MM, Bisson GP, Gupta A, Miyahara S, et al
    Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
    Clin Infect Dis. 2021;73:e870-e877.
    PubMed     Abstract available


  11. KENDALL MA, Lalloo U, Fletcher CV, Wu X, et al
    Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
    Clin Infect Dis. 2021;73:706-715.
    PubMed     Abstract available


    July 2021
  12. KIM S, Cohen T, Horsburgh CR, Miller JW, et al
    Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States.
    Clin Infect Dis. 2021 Jul 29. pii: 6330597. doi: 10.1093.
    PubMed     Abstract available


  13. MATHAD JS, Savic R, Britto P, Jayachandran P, et al
    Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
    Clin Infect Dis. 2021 Jul 29. pii: 6330598. doi: 10.1093.
    PubMed     Abstract available


  14. MOODLEY N, Velen K, Saimen A, Zakhura N, et al
    Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.
    Clin Infect Dis. 2021 Jul 27. pii: 6329140. doi: 10.1093.
    PubMed     Abstract available


  15. KAY AW, Sandoval M, Mtetwa G, Mkhabela M, et al
    Vikela Ekhaya: a novel, community-based, tuberculosis contact management program in a high burden setting.
    Clin Infect Dis. 2021 Jul 24. pii: 6327779. doi: 10.1093.
    PubMed     Abstract available


  16. RADTKE KK, Hesseling AC, Winckler JL, Draper HR, et al
    Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children.
    Clin Infect Dis. 2021 Jul 21. pii: 6324883. doi: 10.1093.
    PubMed     Abstract available


  17. TAVAZIVA G, Harris M, Abidi SK, Geric C, et al
    Chest X-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: an individual patient data meta-analysis of diagnostic accuracy.
    Clin Infect Dis. 2021 Jul 21. pii: 6324830. doi: 10.1093.
    PubMed     Abstract available


  18. WEIR IR, Wasserman S
    Treatment effect measures for culture conversion endpoints in phase IIb tuberculosis treatment trials.
    Clin Infect Dis. 2021 Jul 13. pii: 6319902. doi: 10.1093.
    PubMed     Abstract available


  19. PEETLUK LS, Rebeiro PF, Ridolfi FM, Andrade BB, et al
    A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes.
    Clin Infect Dis. 2021 Jul 2. pii: 6313211. doi: 10.1093.
    PubMed     Abstract available


  20. BAIK Y, Hanrahan CF, Mmolawa L, Nonyane BAS, et al
    Conditional cash transfers to incentivize tuberculosis screening: Description of a novel strategy for contact investigation in rural South Africa.
    Clin Infect Dis. 2021 Jul 2. pii: 6312933. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  21. CHU AL, Murray MB, Huang CC
    Potential role of latent tuberculosis infection in the pathophysiology of cardiovascular disease.
    Clin Infect Dis. 2021 Jun 28. pii: 6310818. doi: 10.1093.
    PubMed    


  22. CEGIELSKI JP, Udwadia ZF, Viiklepp P, Yim JJ, et al
    Reply to van Deun and Decroo.
    Clin Infect Dis. 2021;72:e1168-e1169.
    PubMed    


  23. CHIDAMBARAM V, Tun NL, Majella MG, Ruelas Castillo J, et al
    Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and meta-analysis.
    Clin Infect Dis. 2021 Jun 8. pii: 6294896. doi: 10.1093.
    PubMed     Abstract available


  24. LU P, Liu Q, Zhou Y, Martinez L, et al
    Predictors of Discordant Tuberculin Skin Test and QuantiFERON-TB Gold In-tube Results in Eastern China: A Population-based, Cohort Study.
    Clin Infect Dis. 2021;72:2006-2015.
    PubMed     Abstract available


    May 2021
  25. CHU AL, Lecca LW, Calderon RI, Contreras CC, et al
    Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts.
    Clin Infect Dis. 2021 May 28. pii: 6287936. doi: 10.1093.
    PubMed     Abstract available


  26. XU M, Lu W, Li T, Li J, et al
    Sensitivity, specificity, and safety of a novel ESAT6-CFP10 skin test for tuberculosis infection in China: two randomized, self-controlled, parallel-group phase 2b trials.
    Clin Infect Dis. 2021 May 22. pii: 6280234. doi: 10.1093.
    PubMed     Abstract available


  27. LEE H, Myung W, Lee EM, Kim H, et al
    Mortality and Prognostic Factors of Nontuberculous Mycobacterial Infection in Korea: A Population-based Comparative Study.
    Clin Infect Dis. 2021;72:e610-e619.
    PubMed     Abstract available


  28. MALIK AA, Becerra MC, Lash TL, Cranmer LM, et al
    Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.
    Clin Infect Dis. 2021;72:1709-1715.
    PubMed     Abstract available


  29. NARITA M, Hatt G, Toren KG, Vuong K, et al
    Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
    Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
    PubMed    


  30. MARAIS BJ
    Improved Urine Lipoarabinomannan (LAM) Tests: The Answer for Child Tuberculosis Diagnosis?
    Clin Infect Dis. 2021;72:e289-e290.
    PubMed    


    April 2021
  31. GROBBEL HP, Merker M, Kohler N, Andres S, et al
    Design of multidrug-resistant tuberculosis treatment regimens based on DNA sequencing.
    Clin Infect Dis. 2021 Apr 26. pii: 6253713. doi: 10.1093.
    PubMed     Abstract available


  32. BRUST JCM, Gandhi NR, Wasserman S, Maartens G, et al
    Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study.
    Clin Infect Dis. 2021 Apr 21. pii: 6244470. doi: 10.1093.
    PubMed     Abstract available


  33. HWANG H, Kang H, Kwon YS, Jeon D, et al
    Outcomes of multidrug-resistant tuberculosis treated with bedaquiline or delamanid.
    Clin Infect Dis. 2021 Apr 10. pii: 6219782. doi: 10.1093.
    PubMed     Abstract available


  34. MARAIS BJ
    Good Outcomes in Babies With In Utero Bedaquiline Exposure.
    Clin Infect Dis. 2021;72:1169-1170.
    PubMed    


    March 2021
  35. BALIASHVILI D, Gandhi NR, Kim S, Hughes M, et al
    Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study.
    Clin Infect Dis. 2021 Mar 27. pii: 6193424. doi: 10.1093.
    PubMed     Abstract available


  36. ADU-GYAMFI C, Savulescu D, Mikhathani L, Otwombe K, et al
    Plasma kynurenine-to-tryptophan ratio, a highly sensitive blood-based diagnostic tool for Tuberculosis in HIV-infected pregnant women.
    Clin Infect Dis. 2021 Mar 15. pii: 6170938. doi: 10.1093.
    PubMed     Abstract available


  37. CRESSWELL FV, Meya DB, Kagimu E, Grint D, et al
    High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly HIV-positive Ugandan adults: a phase II open-label randomised controlled trial.
    Clin Infect Dis. 2021 Mar 8. pii: 6159697. doi: 10.1093.
    PubMed     Abstract available


  38. HUANG HL, Huang WC, Lin KD, Liu SS, et al
    Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients with Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.
    Clin Infect Dis. 2021 Mar 3. pii: 6157057. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  39. BURKE RM, Gupta Wright A
    Diagnosing tuberculosis in people with advanced HIV: more is needed.
    Clin Infect Dis. 2021 Feb 26. pii: 6152006. doi: 10.1093.
    PubMed    


  40. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38 +CD27 -TNF-alpha + on Mtb-specific CD4 + T is a robust biomarker for tuberculosis diagnosis.
    Clin Infect Dis. 2021 Feb 19. pii: 6144985. doi: 10.1093.
    PubMed     Abstract available


  41. DU PREEZ K, Osman M, Seddon JA, Naidoo P, et al
    The impact of the evolving HIV response on the epidemiology of tuberculosis in South African children and adolescents.
    Clin Infect Dis. 2021 Feb 3. pii: 6127007. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  42. GUNASEKERA KS, Walters E, van der Zalm MM, Palmer M, et al
    Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis.
    Clin Infect Dis. 2021 Jan 15. pii: 6101512. doi: 10.1093.
    PubMed     Abstract available


  43. HUAMAN MA, De Cecco CN, Bittencourt MS, Ticona E, et al
    Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.
    Clin Infect Dis. 2021 Jan 3. pii: 6060062. doi: 10.1093/cid/ciaa1934.
    PubMed     Abstract available


    December 2020
  44. TACK I, Dumicho A, Ohler L, Shigayeva A, et al
    Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis.
    Clin Infect Dis. 2020 Dec 29. pii: 6054965. doi: 10.1093/cid/ciaa1894.
    PubMed     Abstract available


  45. VAN DEUN A, Decroo T
    How second-line injectable drugs work.
    Clin Infect Dis. 2020 Dec 20. pii: 6042343. doi: 10.1093/cid/ciaa1874.
    PubMed    


  46. YUEN CM, Majidulla A, Jaswal M, Safdar N, et al
    Cost of delivering 12-dose isoniazid and rifapentine versus 6 months of isoniazid for tuberculosis infection in a high-burden setting.
    Clin Infect Dis. 2020 Dec 8. pii: 6025518. doi: 10.1093/cid/ciaa1835.
    PubMed     Abstract available


  47. OH CE, Ortiz-Brizuela E, Bastos ML, Menzies D, et al
    Comparing the Diagnostic Performance of QFT-Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2020 Dec 8. pii: 6026460. doi: 10.1093/cid/ciaa1822.
    PubMed     Abstract available


  48. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
    PubMed     Abstract available


  49. WONG EB
    It is time to focus on asymptomatic tuberculosis.
    Clin Infect Dis. 2020 Dec 6. pii: 6024996. doi: 10.1093/cid/ciaa1827.
    PubMed    


  50. VAN TOORN R, Solomons RS, Seddon JA, Schoeman JF, et al
    Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort.
    Clin Infect Dis. 2020 Dec 6. pii: 6024997. doi: 10.1093/cid/ciaa1826.
    PubMed     Abstract available


    November 2020
  51. ASABOR EN, Vermund SH
    Confronting structural racism in the prevention and control of tuberculosis in the United States.
    Clin Infect Dis. 2020 Nov 26. pii: 6006871. doi: 10.1093/cid/ciaa1763.
    PubMed     Abstract available


  52. HUANG HL, Lee MR, Cheng MH, Lu PL, et al
    Impact of age on outcome of rifapentine-based weekly therapy for latent tuberculosis infection.
    Clin Infect Dis. 2020 Nov 19. pii: 5992466. doi: 10.1093/cid/ciaa1741.
    PubMed     Abstract available


  53. REDDY KP, Denkinger CM, Broger T, McCann NC, et al
    Cost-effectiveness of a novel lipoarabinomannan test for tuberculosis in patients with HIV.
    Clin Infect Dis. 2020 Nov 17. pii: 5983890. doi: 10.1093/cid/ciaa1698.
    PubMed     Abstract available


  54. MONTEPIEDRA G, Kim S, Weinberg A, Theron G, et al
    Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women.
    Clin Infect Dis. 2020 Nov 4. pii: 5955952. doi: 10.1093/cid/ciaa1674.
    PubMed     Abstract available


  55. COLLINS JM, Stout JE, Ayers T, Hill AN, et al
    Prevalence of Latent Tuberculosis Infection among Non-U.S.-Born Persons by Country of Birth - United States, 2012-2017.
    Clin Infect Dis. 2020 Nov 2. pii: 5952274. doi: 10.1093/cid/ciaa1662.
    PubMed     Abstract available


    October 2020
  56. CEGIELSKI JP, Chan PC, Lan Z, Udwadia ZF, et al
    Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016.
    Clin Infect Dis. 2020 Oct 30. pii: 5943503. doi: 10.1093.
    PubMed     Abstract available


  57. ZHENG X, Bao Z, Forsman LD, Hu Y, et al
    Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response.
    Clin Infect Dis. 2020 Oct 18. pii: 5929670. doi: 10.1093/cid/ciaa1569.
    PubMed     Abstract available


  58. KAKAIRE R, Kiwanuka N, Zalwango S, Sekandi JN, et al
    Excess Risk of Tuberculous Infection among Extra-Household Contacts of Tuberculosis Cases in an African City.
    Clin Infect Dis. 2020 Oct 16. pii: 5925052. doi: 10.1093/cid/ciaa1556.
    PubMed     Abstract available


  59. DUFFY D, Nemes E, Llibre A, Rouilly V, et al
    Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection.
    Clin Infect Dis. 2020 Oct 16. pii: 5924452. doi: 10.1093/cid/ciaa1562.
    PubMed     Abstract available


  60. ZELNICK JR, Daftary A, Hwang C, Labar AS, et al
    Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV.
    Clin Infect Dis. 2020 Oct 14. pii: 5923372. doi: 10.1093/cid/ciaa1557.
    PubMed     Abstract available


  61. KUHLIN J, Davies Forsman L, Mansjo M, Jonsson Nordvall M, et al
    Genotypic resistance of pyrazinamide but not MIC is associated with longer time to sputum culture conversion in patients with multidrug-resistant tuberculosis.
    Clin Infect Dis. 2020 Oct 3. pii: 5917759. doi: 10.1093/cid/ciaa1509.
    PubMed     Abstract available


    September 2020
  62. THERON G, Montepiedra G, Aaron L, McCarthy K, et al
    Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV.
    Clin Infect Dis. 2020 Sep 30. pii: 5913421. doi: 10.1093/cid/ciaa1482.
    PubMed     Abstract available


  63. CHIDAMBARAM V, Gupte A, Wang JY, Golub JE, et al
    The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes.
    Clin Infect Dis. 2020 Sep 24. pii: 5911212. doi: 10.1093/cid/ciaa1446.
    PubMed     Abstract available


  64. FRASCELLA B, Richards AS, Sossen B, Emery JC, et al
    Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology.
    Clin Infect Dis. 2020 Sep 16. pii: 5906549. doi: 10.1093/cid/ciaa1402.
    PubMed     Abstract available


  65. DOOKIE N, Padayatchi N, Naidoo K
    Tuberculosis Elimination in the Era of COVID-19: A Moving Target.
    Clin Infect Dis. 2020 Sep 14. pii: 5905579. doi: 10.1093/cid/ciaa1400.
    PubMed    


  66. HAAS MK, Aiona K, Erlandson KM, Belknap RW, et al
    Higher Completion Rates with Self-administered Once-weekly Isoniazid-Rifapentine versus Daily Rifampin in Adults with Latent Tuberculosis.
    Clin Infect Dis. 2020 Sep 11. pii: 5904201. doi: 10.1093/cid/ciaa1364.
    PubMed     Abstract available


    August 2020
  67. LIU Q, Lu P, Shen Y, Li C, et al
    Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China.
    Clin Infect Dis. 2020 Aug 28. pii: 5898659. doi: 10.1093/cid/ciaa1289.
    PubMed     Abstract available


  68. PASIPANODYA J, Gumbo T
    The relationship between drug concentration in tuberculosis lesions, epithelial lining fluid, and clinical outcomes.
    Clin Infect Dis. 2020 Aug 28. pii: 5898607. doi: 10.1093/cid/ciaa1271.
    PubMed    


  69. MCCALLUM AD, Pertinez HE, Else LJ, Dilly-Penchala S, et al
    Intrapulmonary pharmacokinetics of first-line anti-TB drugs in Malawian tuberculosis patients.
    Clin Infect Dis. 2020 Aug 28. pii: 5898506. doi: 10.1093/cid/ciaa1265.
    PubMed     Abstract available


  70. MOOSA MS, Maartens G, Gunter H, Allie S, et al
    A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.
    Clin Infect Dis. 2020 Aug 26. pii: 5897464. doi: 10.1093/cid/ciaa1255.
    PubMed     Abstract available


  71. ROMANOWSKI K, Sobkowiak B, Guthrie JL, Cook VJ, et al
    Using Whole Genome Sequencing to Determine the Timing of Secondary Tuberculosis in British Columbia, Canada.
    Clin Infect Dis. 2020 Aug 19. pii: 5894147. doi: 10.1093/cid/ciaa1224.
    PubMed     Abstract available


  72. CAMPBELL JR, Al-Jahdali H, Bah B, Belo M, et al
    Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials.
    Clin Infect Dis. 2020 Aug 12. pii: 5891810. doi: 10.1093/cid/ciaa1169.
    PubMed     Abstract available


  73. MARTINEZ L, Woldu H, Chen C, Hallowell BD, et al
    Transmission Dynamics in Tuberculosis Patients with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    Clin Infect Dis. 2020 Aug 8. pii: 5889983. doi: 10.1093/cid/ciaa1146.
    PubMed     Abstract available


  74. KUMAR NP, Moideen K, Nancy A, Viswanathan V, et al
    Plasma chemokines are baseline predictors of unfavorable treatment outcomes in pulmonary tuberculosis.
    Clin Infect Dis. 2020 Aug 7. pii: 5885172. doi: 10.1093/cid/ciaa1104.
    PubMed     Abstract available


  75. RAGONNET R, Flegg JA, Brilleman SL, Tiemersma EW, et al
    Revisiting the Natural History of Pulmonary Tuberculosis: a Bayesian Estimation of Natural Recovery and Mortality rates.
    Clin Infect Dis. 2020 Aug 7. pii: 5882189. doi: 10.1093.
    PubMed     Abstract available


  76. NICOL MP, Schumacher SG, Workman L, Broger T, et al
    Accuracy of a novel urine test, Fujifilm SILVAMP TB LAM, for the diagnosis of pulmonary tuberculosis in children.
    Clin Infect Dis. 2020 Aug 6. pii: 5881994. doi: 10.1093/cid/ciaa1052.
    PubMed     Abstract available


  77. PETTIT AC, Stout JE, Belknap R, Benson CA, et al
    Optimal testing choice and diagnostic strategies for latent tuberculosis infection among U.S.-born people living with HIV.
    Clin Infect Dis. 2020 Aug 6. pii: 5881730. doi: 10.1093/cid/ciaa1135.
    PubMed     Abstract available


    July 2020
  78. YOSHIYAMA T, Mitarai S, Takaki A, Aono A, et al
    Multi-drug resistant tuberculosis with simultaneously acquired-drug resistance to bedaquiline and delamanid.
    Clin Infect Dis. 2020 Jul 30. pii: 5879015. doi: 10.1093/cid/ciaa1064.
    PubMed     Abstract available


  79. WEINBERG A, Aaron L, Montepiedra G, Sterling TR, et al
    Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.
    Clin Infect Dis. 2020 Jul 28. pii: 5877271. doi: 10.1093/cid/ciaa1083.
    PubMed     Abstract available


  80. LIU Y, Gao M, Du J, Wang L, et al
    Reduced susceptibility of Mycobacterium tuberculosis to bedaquiline during antituberculosis treatment and its correlation with clinical outcomes in China.
    Clin Infect Dis. 2020 Jul 15. pii: 5871905. doi: 10.1093/cid/ciaa1002.
    PubMed     Abstract available


  81. MIRANDA C, Bark CM
    TB, or not TB, the Choice Is Ours.
    Clin Infect Dis. 2020;71:291-292.
    PubMed    


  82. BOLD TD, Cheng MP, Marty FM
    Reply to Singh.
    Clin Infect Dis. 2020;71:471-472.
    PubMed    


  83. SHU CC, Tsai MK, Lin SW, Wang JY, et al
    Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control.
    Clin Infect Dis. 2020 Jul 4. pii: 5867272. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  84. BISIMWA BC, Nachega JB, Warren RM, Theron G, et al
    Xpert MTB/RIF-detected Rifampicin Resistance is a Sub-Optimal Surrogate for Multidrug Resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Clin Infect Dis. 2020 Jun 26. pii: 5863452. doi: 10.1093.
    PubMed     Abstract available


  85. MARTINEZ L, Andrews JR
    Identifying priorities for testing and treatment of latent tuberculosis infection in the United States.
    Clin Infect Dis. 2020 Jun 26. pii: 5863155. doi: 10.1093.
    PubMed    


  86. NARDELL EA
    Time to revise our tuberculosis infection-latency-disease model in high-burden settings.
    Clin Infect Dis. 2020 Jun 25. pii: 5862697. doi: 10.1093.
    PubMed    


  87. JO Y, Shrestha S, Gomes I, Marks S, et al
    Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas.
    Clin Infect Dis. 2020 Jun 25. pii: 5862678. doi: 10.1093.
    PubMed     Abstract available


  88. JIANG Q, Liu Q, Ji L, Li J, et al
    Citywide Transmission of Multidrug-resistant Tuberculosis Under China's Rapid Urbanization: A Retrospective Population-based Genomic Spatial Epidemiological Study.
    Clin Infect Dis. 2020;71:142-151.
    PubMed     Abstract available


  89. LACOURSE SM, Richardson BA, Kinuthia J, Warr AJ, et al
    A randomized controlled trial of isoniazid to prevent Mycobacterium tuberculosis infection in Kenyan HIV-exposed uninfected infants.
    Clin Infect Dis. 2020 Jun 21. pii: 5860476. doi: 10.1093.
    PubMed     Abstract available


  90. PUYAT JH, Shulha HP, Balshaw R, Campbell JR, et al
    How well does TSTin3D predict risk of active tuberculosis in the Canadian immigrant population? An External Validation Study.
    Clin Infect Dis. 2020 Jun 18. pii: 5859579. doi: 10.1093.
    PubMed     Abstract available


  91. DONOVAN J, Cresswell FV, Thuong NTT, Boulware DR, et al
    Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.
    Clin Infect Dis. 2020 Jun 16. pii: 5858077. doi: 10.1093.
    PubMed     Abstract available


  92. ECKOLD C, Kumar V, Weiner Rd J, Alisjahbana B, et al
    Impact of intermediate hyperglycaemia as well as diabetes on immune dysfunction in tuberculosis.
    Clin Infect Dis. 2020 Jun 13. pii: 5857148. doi: 10.1093.
    PubMed     Abstract available


  93. WILKINSON RJ
    Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
    Clin Infect Dis. 2020 Jun 13. pii: 5857156. doi: 10.1093.
    PubMed    


  94. FOX GJ, Redwood L, Chang V, Ho J, et al
    The effectiveness of individual and environmental infection control measures in reducing the transmission of Mycobacterium tuberculosis: a systematic review.
    Clin Infect Dis. 2020 Jun 5. pii: 5853999. doi: 10.1093.
    PubMed     Abstract available


  95. KARAT AS, Gregg M, Barton HE, Calderon M, et al
    Evidence for the use of triage, respiratory isolation, and effective treatment to reduce the transmission of Mycobacterium tuberculosis in health care settings: a systematic review.
    Clin Infect Dis. 2020 Jun 5. pii: 5852552. doi: 10.1093.
    PubMed     Abstract available


  96. GRIFFITH DE, Cegielski JP
    Tuberculosis Healthcare Workers: There Goes My Hero.
    Clin Infect Dis. 2020 Jun 5. pii: 5853603. doi: 10.1093.
    PubMed    


    May 2020
  97. GAENSBAUER J
    Xpert Ultra assay on children's stool to diagnose pulmonary tuberculosis.
    Clin Infect Dis. 2020 May 25. pii: 5843708. doi: 10.1093.
    PubMed    


  98. CHIANG SS, Brooks MB, Jenkins HE, Rubenstein D, et al
    Concordance of drug resistance profiles between persons with drug-resistant tuberculosis and their household contacts: a systematic review and meta-analysis.
    Clin Infect Dis. 2020 May 25. pii: 5843623. doi: 10.1093.
    PubMed     Abstract available


  99. KABIR S, Rahman SMM, Ahmed S, Islam MS, et al
    Xpert Ultra assay on stool to diagnose pulmonary tuberculosis in children.
    Clin Infect Dis. 2020 May 18. pii: 5839814. doi: 10.1093.
    PubMed     Abstract available


  100. WALLES J, Tesfaye F, Jansson M, Balcha TT, et al
    Tuberculosis infection in women of reproductive age - a cross-sectional study at antenatal care clinics in an Ethiopian city.
    Clin Infect Dis. 2020 May 15. pii: 5837526. doi: 10.1093.
    PubMed     Abstract available


  101. SHIN SS, Modongo C, Zetola NM
    Twice-Daily vs. Once-Daily Dolutegravir in Patients With Human Immunodeficiency Virus-Tuberculosis Coinfection Receiving Rifampicin-Based Tuberculosis Therapy.
    Clin Infect Dis. 2020 May 14. pii: 5836979. doi: 10.1093.
    PubMed    


  102. DOOKIE N, Padayatchi N, Lessells RJ, Naicker CL, et al
    Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing.
    Clin Infect Dis. 2020 May 8. pii: 5834727. doi: 10.1093.
    PubMed     Abstract available


  103. PURYEAR SB, Fatch R, Beesiga B, Kekibiina A, et al
    Higher levels of alcohol use are associated with latent tuberculosis infection in adults living with HIV.
    Clin Infect Dis. 2020 May 6. pii: 5831355. doi: 10.1093.
    PubMed     Abstract available


  104. HORSBURGH CR
    "Plus Ca Change...".
    Clin Infect Dis. 2020;70:2119-2120.
    PubMed    


    April 2020
  105. MARURI F, Guo Y, Blackman A, van der Heijden YF, et al
    Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible M. tuberculosis isolates: a proposed threshold for identifying resistance.
    Clin Infect Dis. 2020 Apr 29. pii: 5827013. doi: 10.1093.
    PubMed     Abstract available


  106. HERMANS SM, Zinyakatira N, Caldwell J, Cobelens FGJ, et al
    High rates of recurrent TB disease: a population-level cohort study.
    Clin Infect Dis. 2020 Apr 25. pii: 5825249. doi: 10.1093.
    PubMed     Abstract available


  107. BOARDMAN NJ, Moore T, Freiman J, Tagliaferri G, et al
    Pulmonary tuberculosis disease among immigrant detainees: rapid disease detection, high prevalence of asymptomatic disease and implications for tuberculosis prevention.
    Clin Infect Dis. 2020 Apr 16. pii: 5820624. doi: 10.1093.
    PubMed     Abstract available


  108. BOUTON TC, Jacobson KR
    Symptom screens are not sufficient: the fight against tuberculosis needs better weapons.
    Clin Infect Dis. 2020 Apr 16. pii: 5820627. doi: 10.1093.
    PubMed    


  109. ALVAREZ GG, Zwerling AA, Duncan C, Pease C, et al
    Molecular epidemiology of Mycobacterium tuberculosis to describe the transmission dynamics among Inuit residing in Iqaluit Nunavut using whole genome sequencing.
    Clin Infect Dis. 2020 Apr 13. pii: 5819740. doi: 10.1093.
    PubMed     Abstract available


  110. ALFFENAAR JC, Gumbo T, Dooley KE, Peloquin CA, et al
    Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis.
    Clin Infect Dis. 2020;70:1774-1780.
    PubMed     Abstract available


  111. REUTER A, Furin J
    Treating drug-resistant tuberculosis infection: no more excuses.
    Clin Infect Dis. 2020 Apr 8. pii: 5817606. doi: 10.1093.
    PubMed    


    March 2020
  112. THOMAS BE, Kumar JV, Chiranjeevi M, Shah D, et al
    Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: Comparison of digital adherence data with urine isoniazid testing.
    Clin Infect Dis. 2020 Mar 28. pii: 5812993. doi: 10.1093.
    PubMed     Abstract available


  113. SCHMIT KM, Wortham JM, Ho CS, Powell KM, et al
    Analysis of severe adverse events reported among patients receiving isoniazid-rifapentine treatment for latent Mycobacterium tuberculosis infection - United States, 2012-2016.
    Clin Infect Dis. 2020 Mar 18. pii: 5809293. doi: 10.1093.
    PubMed     Abstract available


  114. SRINIVASAN V, Ha VTN, Vinh DN, Thai PVK, et al
    Sources of multi-drug resistance in patients with previous isoniazid resistant tuberculosis identified using whole genome sequencing: A longitudinal cohort study.
    Clin Infect Dis. 2020 Mar 13. pii: 5804256. doi: 10.1093.
    PubMed     Abstract available


  115. LOVEDAY M, Hughes J, Sunkari B, Master I, et al
    Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa.
    Clin Infect Dis. 2020 Mar 6. pii: 5788430. doi: 10.1093.
    PubMed     Abstract available


  116. CHENG MP, Marty FM
    Reply to Aronson et al.
    Clin Infect Dis. 2020;70:1262.
    PubMed    


    February 2020
  117. WOODMAN M, Grandjean L
    Detecting Tuberculosis in Prisons: Switching Off the Disease at its Source.
    Clin Infect Dis. 2020 Feb 17. pii: 5736587. doi: 10.1093.
    PubMed    


  118. SANTOS ADS, Oliveira RD, Lemos EF, Lima F, et al
    Yield, Efficiency and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons.
    Clin Infect Dis. 2020 Feb 17. pii: 5736588. doi: 10.1093.
    PubMed     Abstract available


  119. REICHLER MR, Khan A, Yuan Y, Chen B, et al
    Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection.
    Clin Infect Dis. 2020 Feb 11. pii: 5733747. doi: 10.1093/cid/ciz1044.
    PubMed     Abstract available


  120. VAN DER WERF MJ, Rosales-Klintz S, de Vlas SJ
    Screening for Latent Tuberculosis (TB) Infection in Low TB Incidence Countries.
    Clin Infect Dis. 2020;70:716-717.
    PubMed    


  121. MIYAHARA S, Ramchandani R, Kim S, Evans SR, et al
    Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
    Clin Infect Dis. 2020;70:698-703.
    PubMed     Abstract available


    January 2020
  122. KORNFELD H, Sahukar SB, Procter-Gray E, Kumar NP, et al
    Impact of Diabetes and Low Body Mass Index on Tuberculosis Treatment Outcomes.
    Clin Infect Dis. 2020 Jan 19. pii: 5709634. doi: 10.1093.
    PubMed     Abstract available


  123. UGARTE-GIL C, Pearson F, Moore D, Critchley J, et al
    Reply to Yates and Barr.
    Clin Infect Dis. 2020;70:545-546.
    PubMed    


  124. HONG H, Dowdy DW
    Reply to Chen, Song, and Liu.
    Clin Infect Dis. 2020;70:547-548.
    PubMed    


  125. CHEN HL, Song YP, Liu K
    Prediction Model Needs More Improvements Before Clinical Application.
    Clin Infect Dis. 2020;70:546-547.
    PubMed    


  126. PARK JH, Choi EJ, Park HS, Choi SH, et al
    Treatment of latent tuberculosis infection based on the interferon-gamma releasing assay in allogeneic stem cell transplant recipients.
    Clin Infect Dis. 2020 Jan 13. pii: 5701499. doi: 10.1093.
    PubMed     Abstract available


  127. SOSSEN B, Broger T, Kerkhoff AD, Schutz C, et al
    'SILVAMP TB LAM' rapid urine tuberculosis test predicts mortality in hospitalized HIV patients in South Africa.
    Clin Infect Dis. 2020 Jan 9. pii: 5699650. doi: 10.1093.
    PubMed     Abstract available


  128. LI R, Nordio F, Huang CC, Contreras C, et al
    Two clinical prediction tools to improve tuberculosis contact investigation.
    Clin Infect Dis. 2020 Jan 6. pii: 5697300. doi: 10.1093/cid/ciz1221.
    PubMed     Abstract available


  129. RENS NE, Uyl-de Groot CA, Goldhaber-Fiebert JD, Croda J, et al
    Cost-Effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis.
    Clin Infect Dis. 2020 Jan 6. pii: 5697286. doi: 10.1093/cid/ciz1212.
    PubMed     Abstract available


    December 2019
  130. BOGLIONE L, Lipani F, Lucchini AM, Salvador E, et al
    Antiviral therapy in patients with HBV treated for tuberculosis: a forgotten issue.
    Clin Infect Dis. 2019 Dec 17. pii: 5679635. doi: 10.1093/cid/ciz1199.
    PubMed    


  131. KENDALL EA, Malhotra S, Cook-Scalise S, Dowdy DW, et al
    Clinical impact of rapid drug susceptibility testing to accompany fluoroquinolone-containing universal tuberculosis regimens: a Markov model.
    Clin Infect Dis. 2019 Dec 9. pii: 5669959. doi: 10.1093/cid/ciz1179.
    PubMed     Abstract available


  132. NOGUERA-JULIAN A, Calzada-HernAndez J, Brinkmann F, Basu Roy R, et al
    Tuberculosis disease in children and adolescents on therapy with anti-tumor necrosis factor-alpha agents: a collaborative, multi-centre ptbnet study.
    Clin Infect Dis. 2019 Dec 4. pii: 5651260. doi: 10.1093/cid/ciz1138.
    PubMed     Abstract available


  133. NOLT D
    Granulomas and guidelines - the search for tuberculosis during TNF-alpha inhibition.
    Clin Infect Dis. 2019 Dec 4. pii: 5651255. doi: 10.1093/cid/ciz1139.
    PubMed    


    November 2019
  134. GUPTA-WRIGHT A, Fielding K, Wilson D, van Oosterhout JJ, et al
    Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial.
    Clin Infect Dis. 2019 Nov 29. pii: 5645290. doi: 10.1093/cid/ciz1133.
    PubMed     Abstract available


  135. WALSH KF, Koenig SP
    Missed Opportunities with Fatal Consequences: The Need for Earlier Initiation of Intensified Care for Patients at Highest Risk of Mortality from HIV-Associated Tuberculosis.
    Clin Infect Dis. 2019 Nov 29. pii: 5645295. doi: 10.1093/cid/ciz1134.
    PubMed    


  136. FLYNN AG, Aiona K, Haas MK, Reves R, et al
    Clinical Characteristics of Active Tuberculosis Diagnosed after Starting Treatment for Latent Tuberculosis Infection.
    Clin Infect Dis. 2019 Nov 27. pii: 5644105. doi: 10.1093/cid/ciz1157.
    PubMed     Abstract available


  137. MANABE YC, Andrade BB, Gupte N, Leong S, et al
    A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident TB and Mortality in Advanced HIV.
    Clin Infect Dis. 2019 Nov 25. pii: 5639757. doi: 10.1093/cid/ciz1147.
    PubMed     Abstract available


  138. RAVIMOHAN S, Maenetje P, Auld SC, Ncube I, et al
    A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.
    Clin Infect Dis. 2019 Nov 22. pii: 5637499. doi: 10.1093.
    PubMed     Abstract available


  139. KEMPKER RR, Mikiashvili L, Zhao Y, Benkeser D, et al
    Clinical Outcomes among Patients with Drug-resistant Tuberculosis receiving Bedaquiline or Delamanid Containing Regimens.
    Clin Infect Dis. 2019 Nov 12. pii: 5622604. doi: 10.1093/cid/ciz1107.
    PubMed     Abstract available


  140. SEUNG KJ, Khan P, Franke MF, Ahmed S, et al
    Culture conversion at six months in patients receiving delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
    Clin Infect Dis. 2019 Nov 2. pii: 5611120. doi: 10.1093/cid/ciz1084.
    PubMed     Abstract available


    October 2019
  141. SVENSSON EM, Dian S, Te Brake L, Ganiem AR, et al
    Model-based meta-analysis of rifampicin exposure and mortality in Indonesian tuberculosis meningitis trials.
    Clin Infect Dis. 2019 Oct 30. pii: 5609415. doi: 10.1093/cid/ciz1071.
    PubMed     Abstract available


  142. SILVEIRA-MATTOS PS, Barreto-Duarte B, Vasconcelos B, Fukutani KF, et al
    Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T-cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection.
    Clin Infect Dis. 2019 Oct 30. pii: 5609412. doi: 10.1093/cid/ciz1070.
    PubMed     Abstract available


  143. KOENIG SP, Kim A, Shepherd BE, Cesar C, et al
    Increased Mortality after Tuberculosis Treatment Completion in Persons with HIV in Latin America.
    Clin Infect Dis. 2019 Oct 20. pii: 5601170. doi: 10.1093/cid/ciz1032.
    PubMed     Abstract available


  144. NAIDOO K, Hassan-Moosa R, Mlotshwa P, Yende-Zuma N, et al
    High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB
    Clin Infect Dis. 2019 Oct 17. pii: 5589114. doi: 10.1093.
    PubMed     Abstract available


  145. SINGH N
    Unique Rarity of Tuberculosis and Granulomatous Opportunistic Infections in Hematopoietic Cell Transplant Recipients.
    Clin Infect Dis. 2019 Oct 4. pii: 5581232. doi: 10.1093.
    PubMed    


    September 2019
  146. SHAH M, Paradis S, Betz J, Beylis N, et al
    Multicenter Study of the Accuracy of the BD MAX MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid.
    Clin Infect Dis. 2019 Sep 27. pii: 5574845. doi: 10.1093.
    PubMed     Abstract available


  147. KUBJANE M, Berkowitz N, Goliath R, Levitt NS, et al
    Tuberculosis, HIV and the association with transient hyperglycaemia in peri-urban South Africa.
    Clin Infect Dis. 2019 Sep 26. pii: 5574636. doi: 10.1093.
    PubMed     Abstract available


  148. MASE S, Chorba T, Parks S, Belanger A, et al
    Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States.
    Clin Infect Dis. 2019 Sep 26. pii: 5574390. doi: 10.1093.
    PubMed     Abstract available


  149. SWIFT MD, Molella RG, Vaughn AIS, Breeher LE, et al
    Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel.
    Clin Infect Dis. 2019 Sep 25. pii: 5573404. doi: 10.1093.
    PubMed     Abstract available


  150. AULD SC, Maenetje P, Ravimohan S, Weissman D, et al
    Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2019 Sep 25. pii: 5573460. doi: 10.1093.
    PubMed     Abstract available


  151. DU Y, Qiu C, Chen X, Wang J, et al
    Treatment outcome of a shorter regimen containing clofazimine for multidrug-resistant tuberculosis: a randomized control trial in China.
    Clin Infect Dis. 2019 Sep 24. pii: 5573036. doi: 10.1093.
    PubMed     Abstract available


  152. KENYON C, Peeters D, Goedgezelschap A, Vlieghe E, et al
    A Color-conscious Diagnosis.
    Clin Infect Dis. 2019;69:1259-1261.
    PubMed    


  153. MNGQIBISA R, Kendall MA, Dooley K, Wu X, et al
    Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency.
    Clin Infect Dis. 2019 Sep 5. pii: 5561543. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  154. RAVIMOHAN S, Auld SC, Maenetje P, Ratsela N, et al
    Lung injury on antiretroviral therapy in adults with HIV/TB.
    Clin Infect Dis. 2019 Jun 26. pii: 5523721. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  155. THAO LTP, Wolbers M, Heemskerk AD, Thi Hoang Mai N, et al
    Dynamic prediction of death in patients with tuberculous meningitis using time-updated Glasgow coma score and plasma sodium measurements.
    Clin Infect Dis. 2019 Apr 4. pii: 5427068. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  156. ALFFENAAR JC, Heysell SK, Mpagama SG
    Therapeutic Drug Monitoring: The Need for Practical Guidance.
    Clin Infect Dis. 2019;68:1065-1066.
    PubMed    


    August 2018
  157. ROBERTSON K, Oladeji B, Jiang H, Kumwenda J, et al
    HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.
    Clin Infect Dis. 2018 Aug 20. pii: 5076927. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  158. MOORE CC, Jacob ST, Banura P, Zhang J, et al
    Etiology of Sepsis in Uganda using a Quantitative PCR-based TaqMan Array Card.
    Clin Infect Dis. 2018 Jun 4. pii: 5032704. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  159. DIAN S, Rahmadi R, Laarhoven AV, Ganiem AR, et al
    Predicting mortality of tuberculous meningitis.
    Clin Infect Dis. 2018 May 31. pii: 5025876. doi: 10.1093.
    PubMed    


    April 2018
  160. VON REYN CF, Horsburgh CR
    Non-tuberculous mycobacteria and testing for LTBI.
    Clin Infect Dis. 2018 Apr 18. pii: 4975392. doi: 10.1093.
    PubMed    


    March 2018
  161. VAN LAARHOVEN A, Koeken VACM, Dian S, Ganiem AR, et al
    Neuromarker Levels Also Predict Mortality in Adult Tuberculous Meningitis.
    Clin Infect Dis. 2018 Mar 30. pii: 4956701. doi: 10.1093.
    PubMed    


  162. FRIGATI L, Archary M, Rabie H, Penazzato M, et al
    Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Clin Infect Dis. 2018;66.
    PubMed     Abstract available


  163. FORD N, Meintjes G, Calmy A, Bygrave H, et al
    Managing Advanced HIV Disease in a Public Health Approach.
    Clin Infect Dis. 2018;66.
    PubMed     Abstract available


  164. SEKAGGYA-WILTSHIRE C, von Braun A, Lamorde M, Ledergerber B, et al
    Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.
    Clin Infect Dis. 2018 Mar 3. pii: 4919550. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  165. BROOKS KM, George JM, Pau AK, Rupert A, et al
    Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir with Once-Weekly Isoniazid and Rifapentine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836314. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  166. LACOURSE SM, Cranmer LM, Njuguna IN, Gatimu J, et al
    Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.
    Clin Infect Dis. 2018 Jan 6. pii: 4792803. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  167. BRUST JCM, Shah NS, Mlisana K, Moodley P, et al
    Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.
    Clin Infect Dis. 2017 Dec 26. pii: 4774985. doi: 10.1093/cid/cix1125.
    PubMed     Abstract available


    September 2017
  168. THAO LTP, Heemskerk AD, Geskus RB, Mai NTH, et al
    Prognostic models for 9 month mortality in tuberculous meningitis.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  169. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: